Back to Search
Start Over
Insulin at 100: time for action on costs.
- Source :
-
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Mar; Vol. 9 (3), pp. 127. - Publication Year :
- 2021
- Subjects :
- Diabetes Mellitus, Type 1 drug therapy
Diabetes Mellitus, Type 1 economics
Diabetes Mellitus, Type 2 drug therapy
Diabetes Mellitus, Type 2 economics
Endocrinology organization & administration
Endocrinology standards
Government Regulation
History, 21st Century
Humans
Hypoglycemic Agents economics
Hypoglycemic Agents therapeutic use
Insulin therapeutic use
Politics
Practice Guidelines as Topic standards
Societies, Medical standards
Societies, Medical trends
Time Factors
United States
World Health Organization
Drug Costs legislation & jurisprudence
Drug Costs trends
Insulin economics
Legislation, Drug trends
Subjects
Details
- Language :
- English
- ISSN :
- 2213-8595
- Volume :
- 9
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The lancet. Diabetes & endocrinology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33607037
- Full Text :
- https://doi.org/10.1016/S2213-8587(21)00023-1